DCF — LOS ALAMITOS MEDICAL CTR.
Enterprise Value: $-176.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-176.9M
Enterprise Value
$-60.6M
PV of Cash Flows
$-116.4M
PV of Terminal Value
$-187.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $247.0M | $-8.5M | -3.0% | $-19.0M | $-17.3M |
| Year 2 | $254.5M | $-6.2M | -2.0% | $-17.0M | $-14.1M |
| Year 3 | $262.1M | $-3.8M | -1.0% | $-14.9M | $-11.2M |
| Year 4 | $270.0M | $-2.6M | -1.0% | $-14.0M | $-9.6M |
| Year 5 | $278.1M | $-1.9M | -1.0% | $-13.7M | $-8.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-176.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$239.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.039486299689900035
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5